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Abstract  - Here we report on the transformation of tetracyclic morphinan 7 
salutaridine (1) into 2,3,10,11-tetrasubstituted (R)-aporphines. This method 8 
serves as another chemical proof of the previously verified biosynthetic 9 
connection with pentacyclic morphinan-6,8-diene-type thebaine. In the 10 
presence of nucleophiles, this procedure could lead to pharmacologically 11 
interesting new tetrasubstituted aporphinoids. The enantioselective 12 
synthesis of 7S-salutaridinol (2) has been also achieved in order to 13 
investigate the acid-catalyzed reactions of this natural morphinan.  14 
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Introduction 1 
Salutaridine (1) is an alkaloid that is present in the morphinan alkaloid 2 
pathway of opium poppy [1]. Barton and co-workers reported the 3 
transformation (Scheme 1) of (R)-reticuline into salutaridine (1) by a 4 
regioselective para-ortho oxidative coupling [2]. This finding was 5 
confirmed and further investigated by Zenk and co-workers pointing out 6 
the role of cytochrome P-450 linked microsomal enzymes [3]. On the other 7 
hand, salutaridine (1) was converted into (7S)-salutaridinol (2) in the 8 
presence of enzyme salutaridine reductase and accompanied by the 9 
reduction of NADPH to NADP+ [4].  10 
<Scheme 1> 11 
It was also proven that compound 2 could be transformed into thebaine 12 
(Fig. 1) in two steps involving the acetyl coenzyme A catalyzed acetylation 13 
of 7β-hydroxyl function followed by the spontaneous loss of an acetate ion 14 
and a rearrangement [5]. Generally all the known efforts for the chemical 15 
characterization of compound 1 focused on the transformation into (7S)-16 
salutaridinol (2) or the mixture of 7R and 7S stereoisomers of compound 2 17 
[2]. 18 
<Figure 1> 19 
The application of thebaine in the preparation of medically important 20 
opiate analgesics and (partial or full) antagonists [6], new opioid-active 21 
   
 4 
research derivatives [7] and promising dopaminergic aporphinoids [8] has 1 
been considerably increased. Our group reported on the first successful 2 
acid-catalyzed rearrangement of morphinan-5,8-dienes into corresponding 3 
3-substituted-aporphines (Fig. 1) [9]. As a consequence of these results, we 4 
turned our attention to the investigation of the chemical characteristics of 5 
salutaridine (1) and its reduced forms, having the morphinan-5,8-dienone 6 
structure, to explore the possibility of thebaine-like application of this 7 
family of tetracyclic alkaloids.  8 
 9 
Results and Discussion 10 
Salutaridine (1) is readily available from Papaver bracteatum Lindl. [10] 11 
cultivated also in Hungary. Alternatively, biosynthetic [11] and preparative 12 
procedures [2, 12] were also elaborated for this purpose. The acid-13 
catalyzed rearrangement was performed in accordance with the procedure 14 
resulted several selective and active dopaminergic aporphines [13].  15 
<Scheme 2> 16 
The methanesulfonic acid-mediated rearrangement (Scheme 2) resulted 17 
(R)-3,11-dihydroxy-2,10-dimethoxyaporphine (3) in excellent yield (88%). 18 
The substitution pattern of ring A was confirmed by NOESY 19 
measurements confirming short spatial distance between the H1 and OCH3 20 
protons (and no coupling between H4 and OCH3 protons). The R 21 
   
 5 
configuration of C6a carbon was supported by the optical rotation of the 1 
molecule which was found to be [α]D
20= -108 (c=0.2 in methanol). This 2 
value confirms R configuration in view of previous results for (R)- and (S)-3 
aporphines (approx. -130 vs. +130, respectively) with similar substitution 4 
[14] as well as 1H-NMR chemical shifts of H6a (vide infra). It might be 5 
interesting to note that 2,3,10,11-tetrasubstituted aporphines form a small 6 
family of the aporphinoids [15a], therefore this methodology could lead to 7 
preparation and characterization of several new member of this group of 8 
alkaloids. Up to now there was no procedure described for the synthesis of 9 
such tetrasubstituted aporphines, however the successful isolation of the 10 
2,3-dihydroxy-10,11-dimethoxy congener was reported from Chinese 11 
Magnolia cortex [15b]. 12 
In view of our previous mechanistic explanation for the rearrangement of 13 
morphinan-5,8-dienes [9] the following (Scheme 3) a protonation-induced, 14 
aromatization-driven mechanism is suggested for this reaction of 15 
salutaridine (1).  16 
<Scheme 3> 17 
The phenomenon of nucleophilic transetherification of the intermediary 18 
methoxonium ion was first observed in the course of rearrangement 19 
experiments of thebaine in methanesulfonic acid [16]. In the presence of an 20 
alcohol (ROH) the main rearrangement product was identified as the 21 
   
 6 
corresponding 2-OR-apocodeine besides the 2-OMe-aporphine. This 1 
observation was efficiently used in the synthesis of pharmacologically 2 
active compounds [17] and tested also in the case of salutaridine (1, 3 
Scheme 4).  4 
<Scheme 4> 5 
The application of methanol gave rise to 11-hydroxy-2,3,10-6 
trimethoxyaporphine (4) in good yield. As it was expected these reactions 7 
with ethanol and n-propanol produced mixtures of aporphine derivatives. 8 
The confirmation of the substitution pattern of the ring A of these new 9 
aporphinoids was based on NOESY measurements. The most relevant 10 
couplings were denoted in Scheme 4. The obtained yields of these 11 
rearrangements are summarized in Table 1.  12 
<Table 1> 13 
The usual analytical characterization of the products confirmed the 14 
possibility of (trans)etherification at both positions 2 and 3. As the 15 
production of 3-hydroxy-type aporphines was not observed it was 16 
concluded that position 3 was more sensitive to the ether formation. In 17 
view of the commonly accepted mechanism of the acid-catalyzed 18 
rearrangement of morphinan-6,8-dienes [18] and our suggested 19 
intermediate of the rearrangement of morphinan-5,8-dienes [9] the C3-20 
OHàC3-OR etherification could lead to the stabilization of this structure. 21 
   
 7 
7S-Salutaridinol (2) is the natural reduction product of compound 1 which 1 
plays important role in the biosynthesis of opiates [2, 5, 19]. Besides 2 
biosynthetic procedures [5, 19] only one chemical route was schemed [2] 3 
for the production of (7S)-2 comprising the nonselective sodium 4 
borohydride-mediated reduction of 1 and column chromatography 5 
separation of the equimolar mixture of the two epimers. On the basis of 6 
literature examples for the enatioselective reductions of highly sensitive 7 
ketones with K-Selectride (1.0 M potassium tri-sec-butylborohydride in 8 
THF) [20] and our previous positive experience with this reagent in the 9 
selective reduction of 6-keto function of morphinones [21], salutaridine (1) 10 
was subjected to a thematic study. Absolute THF was used as a solvent and 11 
reactions were run at 0oC meanwhile the applied amount of K-Selectride 12 
was changed from 2 equivalents (eq.) to 10 equivalents related to starting 13 
alkaloid 1. It was observed that the treatment of compound 1 with 5 eq. of 14 
the borohydride in 16 hours at 0oC and further 5 hours at room temperature 15 
gave rise to 7S-salutaridinol (2) as the main product in 66% yield (Scheme 16 
5) besides minor products and some unreacted salutaridine (1).    17 
<Scheme 5> 18 
In order to reveal the basic reason for the observed selectivity of the K-19 
Selectride-mediated reduction, the high level DFT-optimized geometry of 20 
salutaridine (1) was constructed. In view of the conformation of ring A of 21 
   
 8 
the morphinan (Fig. 2) the spatial hindrance from the direction of ring A 1 
could be responsible for the selectivity. 2 
<Figure 2> 3 
Having on one hand the equimolar mixture of 7S-salutaridinol (2) and 7-4 
epi-salutaridinol (7R, 2) obtained in line with the procedure of Barton et al. 5 
[2] and on the other hand the pure 7S-salutaridinol (2) it was targeted to 6 
extend the knowledge on the acid-catalyzed reactions of these tetracyclic 7 
alkaloids.  8 
<Scheme 6> 9 
Interestingly, it was observed that regardless of using the equimolar 10 
mixture of salutaridinol (2) and 7-epi-salutaridinol (7R, 2) or salutaridinol 11 
(7S, 2) the resulting mixture contained two well-known aporphinoids 12 
(Scheme 6); (R)-2,11-dihydroxy-10-methoxyaporphine (morphothebaine, 13 
9) and its 2-methoxy congener 10. There was only a slight difference in the 14 
ratio of the isolated yields in the two sets of experiments. The explanation 15 
for this behavior should be in accordance with a previous observation [16] 16 
regarding the formation of 2-hydroxy- and 2-methoxyaporphine-type 17 
products from morphinan-6,8-dienes in methanesulfonic acid catalyzed 18 
rearrangement in the presence of water traces. 19 
   
 9 
Taking into account the suggested mechanism for the rearrangement of 1 1 
(Scheme 3) in this case the formation of methoxonium intermediate occurs 2 
via the elimination and successive attack of a water molecule (Scheme 7). 3 
<Scheme 7> 4 
Conclusion 5 
In this study we have presented the possibility of the acid-catalyzed 6 
rearrangement of tetracyclic morphinan salutaridine (1) into 2,3,10,11-7 
tetrasubstituted (R)-aporphines. This method is another chemical proof of 8 
the previously verified biosynthetic connection with pentacyclic 9 
morphinan-6,8-diene-type thebaine. On the other hand, this procedure 10 
could lead to pharmacologically interesting new aporphinoids. The 11 
enantioselective synthesis of 7S-saluraridinol (2) has been also achieved in 12 
order to investigate the acid-catalyzed reactions of this natural morphinan. 13 
These reactions afforded well-known 2,10,11-trisubstituted (R)-aporphines. 14 
It is worthwhile to note that the dextrorotatory morphinan sinoacutine, the 15 
9,13-diastereomer of salutaridine (1), also available in nature [22] and with 16 
similar rearrangement reactions it would be possible to obtain (S)-17 
aporphines for the first time.  18 
 19 
   
 10 
Experimental 1 
Melting points were determined with a Kofler hot-stage apparatus and are 2 
uncorrected. Thin layer chromatography was performed on pre-coated 3 
Merck 5554 Kieselgel 60 F254 foils using dichloromethane 4 
(DCM)/methanol = 8/2 mobile phase. The spots were visualized with 5 
Dragendorff’s reagent. 
1H and 13C NMR 1D spectra and phase-sensitive ge-6 
2D NOESY experiments were recorded at 400 MHz using a Bruker 7 
Avance DRX400 spectrometer; chemical shifts are reported in parts per 8 
million (δ) from internal TMS and coupling constants (J) are measured in 9 
hertz. Mass spectral measurements were performed with a Bruker 10 
micrOTOF-Q instrument in the ESI mode. Optical rotation was determined 11 
with a Perkin Elmer Model 241 polarimeter. Elemental analyses (C, H) 12 
were obtained on a Carlo Erba EA1108 analyzer. 13 
 14 
Salutaridine (1) from natural source 15 
The latex of Papaver bracteatum Lindl. was processed in accordance with 16 
the method of Slavík and Slavíkova [23]. Physical and basic spectral 17 
characteristics are in accordance with previously reported data [12]. M.p.: 18 
196-199oC (lit. 197-198oC [2]). Calculated for free base C19H21NO4: C, 19 
69.71; H, 6.74;  found: C, 69.29; H, 6.71; MS (ESI) m/z 328.2 (M+H+), 20 
calculated for C19H22NO4
+: 328.1; 1H-NMR (CDCl3) δ=7.53 (s, 1H, H8), 21 
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6.74 (d, 1H, H1, J1-2=8.1), 6.65 (d, 1H, H2, J1-2=8.1), 6.32 (s, 1H, H5), 6.25 1 
(br s, 1H, OH), 3.88 (s, 3H, OCH3), 3.75 (s, 3H, OCH3), 3.67 (dd, 1H, H9, 2 
J=4.6, <2), 3.32 (d, 1H, H10α, J10α-10β= 16.4),  2.98 (m, 1H, H10β), 2.63-3 
2.31 (m, 6H, H15β, H16α, H16β, NCH3), 1.76 (ddd, 1H, H15α, J =5.2, <2, 4 
<2). 13C-NMR (CDCl3) δ=181.4, 161.4, 151.0, 145.3, 143.3, 129.8, 124.0, 5 
122.2, 120.3, 118.8, 109.4, 61.1, 56.3, 54.8, 47.0, 43.6, 41.7, 37.7, 32.7. 6 
7S-Salutaridinol (2) 7 
Compound 1 (72 mg, 0.22 mmol) was dissolved in absolute THF under 8 
argon atmosphere and stirred at 0oC. K-Selectride (1.1 mL, 1M in THF, 1.1 9 
mmol) was added dropwise. The solution was stirred at 0oC for 16 hours 10 
and at room temperature for another 5 hours. The reaction mixture was 11 
quenched with 4 mL of 96% ethanol and the solvents were removed under 12 
reduced pressure. The remaining solid was dissolved in 10 mL of saturated 13 
NaHCO3 solution and extracted with ethyl acetate (3 x 10 mL). After 14 
washing with brine, drying on MgSO4 the solvent was removed completely 15 
and the remaining solid was subjected to column chromatography 16 
(Kieselgel 40, eluent: DCM/MeOH = 8/2). The off-white solid was found 17 
to be 49 mg (yield: 66%). Physical and basic spectral characteristics are in 18 
accordance with previously reported data [2, 19]. M.p.: 132-134oC (lit. 19 
132-140oC [2]). Calculated for free base C19H23NO4: C, 69.28; H, 7.04;  20 
found: C, 69.17; H, 7.13; MS (ESI) m/z 330.2 (M+H+), calculated for 21 
   
 12 
C19H24NO4
+: 330.2; 1H-NMR (CD3OD) δ=6.77 (d, 1H, H1, J1-2=8.0), 6.68 1 
(d, 1H, H2, J1-2=8.0), 6.42 (s, 1H, H5), 5.63 (d, 1H, H8, J8-7β=4.1), 4.49 (d, 2 
1H, H7β, J8-7β=4.1), 3.86 (s, 3H, OCH3), 3.73 (s, 3H, OCH3), 3.61 (dd, 1H, 3 
H9, J=4.2, <2), 3.29 (d, 1H, H10α,  J10α-10β= 15.6),  2.99 (m, 1H, H10β), 4 
2.60-2.25 (m, 6H, H15β, H16α, H16β, NCH3), 1.80 (ddd, 1H, H15α, J=5.0, 5 
<2, <2). 13C-NMR (CD3OD) δ=158.3, 145.1, 143.7, 135.8, 128.4, 124.6, 6 
121.2, 118.7, 109.8, 91.7, 76.4, 62.1, 56.3, 55.2, 48.0, 43.8, 40.7, 37.7, 7 
31.4. 8 
Acid-catalyzed rearrangement of salutaridine (1) and salutaridinols (2) 9 
A mixture of 1 or 2 (0.71 mmol) and 99.5% methanesulfonic acid (1 ml) 10 
was stirred for 30 min at 90 oC. Then the reaction mixture was added 11 
dropwise, with stirring and external ice-cooling, to a solution of potassium 12 
hydrogen carbonate (2 g) in water (10 ml). After extraction with 13 
dichloromethane (3x15 ml), the combined extracts were washed with 14 
saturated brine, dried (MgSO4), and concentrated under reduced pressure. 15 
The purification was performed by means of column chromatography 16 
(Kieselgel 40, eluent: DCM/MeOH = 8/2).  17 
(R)-3,11-dihydroxy-2,10-dimethoxyaporphine (3) 18 
Yield: 88% starting from compound 1. Pale green solid. M.p.: 132-134oC. 19 
[α]D
25 -108 (c=0.2 in methanol); calculated for free base C19H21NO4: C, 20 
69.71; H, 6.47;  found: C, 69.67; H, 6.59; MS (ESI) m/z 327.2 (M+H+), 21 
   
 13 
calculated for C19H22NO4
+: 327.2; 1H-NMR (CDCl3) δ=7.95 (s, 1H, H1), 1 
6.75 (d, 1H, H8, J8-9=7.4), 6.71 (d, 1H, H9, J8-9=7.4), 5.20 (br s, 2H, 2 OH), 2 
3.92 (s, 6H, 2 OCH3), 3.48 (dd, 1H, H6a, J=4.4, <2), 3.15-2.86 (m, 3H, 3 
H7α, H7β, H5α), 2.62-2.41 (m, 6H, H4α, H4β, H5β, NCH3); 
13C-NMR 4 
(CDCl3) δ=150.3, 147.4, 144.3, 140.2, 130.9, 128.6, 128.4, 127.2, 126.7, 5 
119.8, 112.2, 110.5, 64.2, 56.4, 56.2, 52.4, 43.8, 34.7, 28.4. 6 
(R)-2,11-dihydroxy-10-methoxyaporphine (morphothebaine, 9)  7 
Yield from the equimolar mixture of 2 epimers: 31%, yield from pure 7S-8 
salutaridinol (2): 37%. M.p. as an HCl salt: 257-258oC (lit.: 258-260oC 9 
[24]). All the physical and spectral data were fully in agreement with 10 
previously published data [24]. 11 
(R)-2,10-Dimethoxy-11-hydroxyaporphine (10) 12 
Yield from the equimolar mixture of 2 epimers: 37%, yield from pure 7S-13 
salutaridinol (2): 41%. M.p.: 150-151oC (lit.: 149-151oC [16]). All the 14 
physical and spectral data were fully in agreement with previously 15 
published data [16]. 16 
Acid-catalyzed rearrangement of salutaridine (1) in the presence of 17 
alcohols  18 
A mixture of 1 (233 mg, 0.71 mmol), methanesulfonic acid (1 mL) and 19 
alcohol (200 μL) was stirred for 30 min at 90 oC. Then the reaction mixture 20 
was added dropwise, with stirring and external ice-cooling, to a solution of 21 
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potassium hydrogen carbonate (2 g) in water (10 mL). After extraction with 1 
dichloromethane (3x15 mL), the combined extracts were washed with 2 
saturated brine, dried (MgSO4), and concentrated under reduced pressure. 3 
The purification of was performed by means of column chromatography 4 
(Kieselgel 40, eluent: DCM/MeOH = 9/1).  5 
(R)-11-Hydroxy-2,3,10-trimethoxyaporphine (4) 6 
Yield: 78% starting from compound 1. Off-white solid. M.p.: 114-116oC. 7 
[α]D
25 -118 (c=0.2 in methanol); calculated for free base C20H23NO4: C, 8 
70.36; H, 6.79;  found: C, 70.19; H, 6.89; MS (ESI) m/z 342.2 (M+H+), 9 
calculated for C20H24NO4
+: 342.2; 1H-NMR (CDCl3) δ=8.01 (s, 1H, H1), 10 
6.71 (d, 1H, H8, J8-9=7.7), 6.68 (d, 1H, H9, J8-9=7.7), 5.15 (br s, 1H,  OH), 11 
3.94 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 3.39 (dd, 1H, 12 
H6a, J=4.5, <2), 3.19-2.87 (m, 3H, H7α, H7β, H5α), 2.67-2.39 (m, 6H, 13 
H4α, H4β, H5β, NCH3); 
13C-NMR (CDCl3) δ=149.7, 148.5, 147.3, 144.3, 14 
135.2, 133.9, 127.6, 126.4, 126.2, 120.3, 111.7, 108.5, 66.2, 61.1, 56.4, 15 
56.2, 52.3, 43.5, 34.5, 28.1. 16 
(R)-2,10-Dimethoxy-3-ethoxy-11-hydroxyaporphine (5) 17 
Yield: 48% starting from compound 1. Off-white foam. [α]D
25 -101 (c=0.2 18 
in methanol); calculated for free base C21H25NO4: C, 70.96; H, 7.01;  19 
found: C, 70.77; H, 7.11; MS (ESI) m/z 355.1 (M+H+), calculated for 20 
C21H26NO4
+: 355.2; 1H-NMR (CDCl3) δ=8.07 (s, 1H, H1), 6.74 (d, 1H, H8, 21 
   
 15 
J8-9=7.6), 6.70 (d, 1H, H9, J8-9=7.6), 5.09 (br s, 1H, OH), 4.11 (dd, 2H, 1 
OCH2, J=5.8), 3.86 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 3.39 (dd, 1H, H6a, 2 
J=4.6, <2), 3.19-2.83 (m, 3H, H7α, H7β, H5α), 2.59-2.39 (m, 6H, H4α, 3 
H4β, H5β, NCH3), 1.35 (t, 3H, CH2CH3, J=6.8); 
13C-NMR (CDCl3) 4 
δ=148.9, 147.5, 144.3, 143.9, 132.9, 130.8, 127.0, 126.8, 126.2, 120.8, 5 
110.6, 109.1, 65.1, 64.2, 56.3, 56.2, 51.7, 43.6, 35.2, 28.4, 17.3. 6 
(R)-2,10-Dimethoxy-11-hydroxy-3-propoxyaporphine (6) 7 
Yield: 40% starting from compound 1. Pale grey solid. M.p.: 121-123oC. 8 
[α]D
25 -99 (c=0.2 in methanol); calculated for free base C22H27NO4: C, 9 
71.52; H, 7.37;  found: C, 71.67; H, 7.44; MS (ESI) m/z 370.2 (M+H+), 10 
calculated for C22H28NO4
+: 370.2; 1H-NMR (CDCl3) δ=8.07 (s, 1H, H1), 11 
6.71 (d, 1H, H8, J8-9=7.8), 6.66 (d, 1H, H9, J8-9=7.8), 5.09 (br s, 1H, OH), 12 
4.05 (dd, 2H, OCH2, J=5.4), 3.93 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 3.39 13 
(dd, 1H, H6a, J=4.6, <2), 3.21-2.89 (m, 3H, H7α, H7β, H5α), 2.59-2.33 (m, 14 
6H, H4α, H4β, H5β, NCH3),1.71 (ddd, 2H, OCH2CH2, J=5.4), 0.96 (t, 3H, 15 
CH2CH3, J=5.4); 
13C-NMR (CDCl3) δ=149.4, 148.3, 145.3, 144.2, 133.6, 16 
130.9, 127.4, 126.9, 126.7, 121.0, 112.2, 109.6, 71.1, 64.6, 56.4, 56.3, 51.7, 17 
43.4, 35.2, 29.2, 27.6, 10.7. 18 
(R)-2,3-Diethoxy-11-hydroxy-10-methoxyaporphine (7) 19 
Yield: 33% starting from compound 1. Off-white solid. M.p.: 101-103oC; 20 
[α]D
25 -119 (c=0.2 in methanol); calculated for free base C22H27NO4: C, 21 
   
 16 
71.52; H, 7.37;  found: C, 71.77; H, 7.41; MS (ESI) m/z 370.1 (M+H+), 1 
calculated for C22H28NO4
+: 370.2; 1H-NMR (CDCl3) δ=8.11 (s, 1H, H1), 2 
6.78 (d, 1H, H8, J8-9=7.7), 6.74 (d, 1H, H9, J8-9=7.7), 5.01 (br s, 1H, OH), 3 
4.09-4.03 (m, 4H, 2 OCH2), 3.91 (s, 3H, OCH3), 3.36 (dd, 1H, H6a, J=4.4, 4 
<2), 3.16-2.79 (m, 3H, H7α, H7β, H5α), 2.66-2.32 (m, 6H, H4α, H4β, H5β, 5 
NCH3), 1.32-1.29 (m, 6H, 2 CH2CH3); 
13C-NMR (CDCl3) δ=148.2, 146.2, 6 
145.1, 144.0, 133.1, 129.8, 126.9, 126.4, 125.9, 121.0, 112.1, 109.6, 65.7, 7 
64.3, 64.1, 56.4, 56.2, 51.2, 43.4, 36.5, 28.4, 16.1, 15.9. 8 
 (R)-2,3-Dipropoxy-11-hydroxy-10-methoxyaporphine (8) 9 
Yield: 29% starting from compound 1. Grey solid. M.p.: 101-103oC. [α]D
25 10 
-112 (c=0.2 in methanol); calculated for free base C24H31NO4: C, 72.52; H, 11 
7.86;  found: C, 72.61; H, 7.92; MS (ESI) m/z 398.2 (M+H+), calculated 12 
for C24H32NO4
+: 398.2; 1H-NMR (CDCl3) δ=8.00 (s, 1H, H1), 6.75 (d, 1H, 13 
H8, J8-9=7.6), 6.70 (d, 1H, H9, J8-9=7.6), 5.00 (br s, 1H, OH), 4.12-4.05 (m, 14 
4H, 2 OCH2), 3.91 (s, 3H, OCH3), 3.33 (dd, 1H, H6a, J=4.4, <2), 3.26-2.90 15 
(m, 3H, H7α, H7β, H5α), 2.54-2.31 (m, 6H, H4α, H4β, H5β, NCH3),1.79-16 
1.71 (m, 4H, 2 OCH2CH2), 1.01-0.96 (m, 6H, 2 CH2CH3); 
13C-NMR 17 
(CDCl3) δ=148.1, 147.5, 145.1, 144.6, 133.1, 132.7, 127.5, 127.0, 126.5, 18 
121.6, 111.2, 109.7, 71.2, 69.8, 65.7, 56.4, 51.3, 43.7, 34.9, 23.5, 22.9, 19 
10.7, 10.5. 20 
Computational procedure 21 
   
 17 
We have carried out the geometry optimization at Becke’s three parameter 1 
hybrid (B3LYP) [25] levels in the DFT with the basis set 6-31G* using 2 
Gaussian 03 [26] and solvent effect was not considered. 3 
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 1 
Tables 2 
Table 1. Results of the corresponding rearrangement reactions of 1 in the 3 
presence of alcohols (ROH) 4 
*after column chromatography 5 
6 
 
ROH 
Isolated yields (%)
*
 
2-OMe-3-OR-aporphine (4-6) 2,3-di-OR-aporphine (7, 8) 
Methanol 78 - 
Ethanol 48 33 
n-Propanol 40 29 
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 1 
Figures and Schemes 2 
3 
Scheme 1. The role of salutaridine (1) in the formation of opium alkaloids 4 
 5 
 6 
 7 
Figure 1. Stucture of morphinandienes and their acid-catalyzed 8 
rearrangement product, apocodeine 9 
 10 
 11 
 12 
 13 
Scheme 2. Acid-catalyzed rearrangement of salutaridine (1) 14 
 15 
 16 
   
 23 
1 
Scheme 3. Plausible mechanism for the acid-catalyzed rearrangement of 1 2 
 3 
 4 
5 
Scheme 4. Acid-catalyzed rearrangement of 1 in the presence of alcohols 6 
 7 
 8 
 9 
Scheme 5. Modified synthesis of 7S-salutaridinol (2) 10 
 11 
 12 
 13 
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 1 
Figure 2. Presentation of the attack of tri-sec-butylborohydride ion to the 2 
DFT-optimized structure of compound 1 3 
 4 
 5 
 6 
Scheme 6. Acid-catalyzed rearrangement experiments of salutaridinol (2) 7 
epimers 8 
 9 
 10 
11 
 12 
Scheme 7. Suggested mechanism for the rearrangement of salutaridinols 2 13 
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 1 
Graphical Abstract 2 
Salutaridine and its derivatives as thebaine-equivalents 3 
in the synthesis of aporphines 4 
 5 
Antal Udvardy ● Attila Sipos
 6 
 7 
 8 
